Researchers Discover Gut Microbiome Differences in a Rare Form of Mitochondrial Diabetes

People living with mitochondrial disease caused by the m.3243 A > G genetic mutation commonly experience gastrointestinal complaints and problems with gut movement. Researchers have suspected that changes in the gut microbiome—the community of bacteria living in the digestive tract—might play a role in these digestive issues.

Since previous research has shown that other forms of diabetes are linked to alterations in the gut microbiome, scientists wondered whether the same might be true for MIDD (Maternally Inherited Diabetes and Deafness), a common condition associated with this mitochondrial mutation.

To investigate, researchers analyzed fecal samples from 30 people with the m.3243 A > G mitochondrial mutation using advanced genetic sequencing techniques. They compared these samples to bacteria from 60 healthy control subjects and 60 people with Type 1 diabetes, carefully matching participants by age, sex, and body mass index to make fair comparisons.

The gut bacteria composition of people with the mitochondrial mutation differed significantly from both healthy controls and people with Type 1 diabetes. Specifically, people with the m.3243 A > G mutation had lower levels of Faecalibacterium prausnitzii—a bacteria generally considered beneficial—and higher levels of potentially harmful bacteria including Escherichia coli, Ruminococcus gnavus, and Ruminococcus torques.

Interestingly, this bacterial pattern resembles what researchers observe in inflammatory bowel disease, a condition linked to problems with how mitochondria function in intestinal cells.

This exploratory study suggests that the m.3243 A > G mitochondrial mutation creates a unique signature in the gut microbiome that differs from both healthy individuals and people with Type 1 diabetes. The similarities to inflammatory bowel disease patterns hint at possible connections between mitochondrial function and gut inflammation.

However, this research is early-stage. It identifies an association worth investigating further but does not yet explain whether these bacterial changes cause the digestive problems people with this condition experience, or whether they are a consequence of the disease. Future studies will be needed to understand these relationships and determine whether targeting the microbiome could help manage symptoms.

Source: Molecular genetics and metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.